Dear Reader,
The disease burden of Type 2 diabetes mellitus (T2DM) is substantial, with 14% of adults aged 18 or older living with the disease globally in 2022. Instead of considering T2DM as an individual disorder, there are emerging concerns about the interrelations between T2DM and various complications. In particular, the pathophysiology and treatment strategies for T2DM with co-morbid cardiovascular disease (CVD) have been extensively investigated due to its high prevalence. The co-existence of the disorders can worsen each other, leading to poor health outcomes. Thus, early identification of high-risk individuals and timely treatment are key to improving patient outcomes. Accordingly, there have been numerous investigations on biomarkers aiming to predict the CVD risk in patients with T2DM. In the current Feature Story, the treatment strategies against CVD in T2DM patients and recent findings on biomarker research will be highlighted.
In the Focus section, innovations in managing prostate cancer will be discussed. Remarkably, the applications of artificial intelligence (AI) in facilitating personalising treatment will be reviewed. In addition to the thematic topics, updates on pharmacologic management of viral hepatitis, bipolar depression, hyperphosphatemia, and multiple myeloma are featured in the Industry Updates.
Since the 1st Issue of V.Pulse was published in December 2018, I have had the privilege of serving as the Chief Editor of this amazing publication and witnessing its development. To fulfil the aim of V.Pulse to provide local medical practitioners with an update on medical breakthroughs, our Editorial Team is devoted to exploring innovations in various clinical disciplines. We hope V.Pulse to be not only a leisure reading for healthcare professionals but also a reference that benefits their clinical practice. Thus, we seek CME approval for selected V.Pulse articles and have launched the mobile app to ensure easy access.
After 7 years of service at V.Pulse, it is an appropriate time for me to step down from my current position and move on to the next chapter. Meanwhile, I would like to take this opportunity to thank all the healthcare professionals who contributed valuable clinical opinions to V.Pulse. I would also like to thank our sponsors for their trust and support. Moreover, the great effort of the Editorial Team put in producing V.Pulse is deeply appreciated. Last but not least, I would like to thank you, all readers, for your continuous support, which makes V.Pulse possible and sustainable. Thank you!
Farewell, and hope you enjoy this issue.
Dr. Roy Yuen-chi Lau
PhD, DBA, MPH, MMedSc, MA, BSc, FRSPH, MIET, MRSC, MSB, CBiol, CSci, MRACI CChem
Editor-in-Chief
To provide articles that match your interest, a V∙Pulse Reader Survey has been launched to collect your opinions on the preferred topics.
